Immunomodulatory effect of mesenchymal stem cells: Cell origin and cell quality variations
- 46 Downloads
The immunomodulatory property of mesenchymal stem cells (MSCs) has been previously reported. Still it is unclear if this property can be affected by the cell origin and cell quality. Using primary MSCs expanded from bone marrow (BM-MSCs) and adipose tissue (AD-MSCs) of mice, we investigated whether the immunomodulatory property of MSCs varied with cell origin and cell quality (early- vs. late-passaged BM-MSCs). BM-MSCs (p1) and AD-MSCs (p1) had a typical spindle shape, but morphological changes were observed in late-passaged BM-MSCs (p6). A pathway-focused array showed that the expression of chemokine/cytokine genes varied with different cell origins and qualities. By co-culturing with spleen mononuclear cells (MNC) for 3 days, the expression of CD4 was suppressed by all types of MSCs. By contrast, the expression of CD8 was suppressed by BM-MSCs and increased by AD-MSCs. The expression ratio of CD206 to CD86 was at a comparable level after co-culture with AD-MSCs and BM-MSCs, but was lower with late-passaged BM-MSCs. AD-MSCs highly induced the release of IL6, IL-10 and TGF-β in culture medium. Compared with early-passaged BM-MSCs (p1), late-passaged BM-MSCs (p6) released less TGF-β. Our data suggests that the immunomodulatory properties of MSCs vary with cell origin and cell quality and that BM-MSCs of good quality are likely the optimal source of immunomodulation.
KeywordsMesenchymal stem cell BM-MSC AD-MSC Immunomodulation T cell Macrophage
This study was supported by the Ministry of Higher Education, Egypt and a Grant-in-Aid from the Ministry of Education, Science, Sports, Culture and Technology, Japan.
Compliance with ethical standards
The authors declare that they have no competing interests.
All experiments were approved by the Institutional Animal Care and Use Committee of Nagasaki University and performed in accordance with the institutional and national guidelines.
- 4.Abreu SC, Antunes MA, Xisto DG et al (2017) Bone marrow, adipose, and lung tissue-derived murine mesenchymal stromal cells release different mediators and differentially affect airway and lung parenchyma in experimental asthma. Stem Cells Transl Med. https://doi.org/10.1002/sctm.16-0398 Google Scholar
- 16.Kang SG, Shinojima N, Hossain A et al (2010) Isolation and perivascular localization of mesenchymal stem cells from mouse brain. Neurosurgery. https://doi.org/10.1227/01.NEU.0000377859.06219.78 Google Scholar
- 21.Zhou Y, Day A, Haykal S et al (2013) Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway. Cytotherapy. https://doi.org/10.1016/j.jcyt.2013.05.009
- 24.Duijvestein M, Vos AC, Roelofs H et al (2010) Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study. Gut. https://doi.org/10.1136/gut.2010.215152